Browsing Tag
Melbourne
49 posts
Synertec (ASX: SOP) drops as Hitachi Energy collaboration excitement fades into post-update profit-taking
Synertec just signed Hitachi Energy. The Powerhouse is AI-powered grid tech. The market cap is A$12m. The analyst consensus target is 400% above current.
May 10, 2026
Tabcorp (ASX: TAH) collapse deepens as AUSTRAC compliance probe revives 2017 AML breach memories
Tabcorp paid A$45m for AML breaches in 2017. AUSTRAC just sent another letter. The market priced in the worst case before management could speak.
May 10, 2026
REA Group (ASX: REA) shares jump as Q3 FY2026 result lifts cost guidance and confirms residential recovery
REA Group fell 9.6% on H1 results in February. Today's Q3 print rewrites that thesis. Listing volumes are back, yield is at 14%, costs are being held.
May 8, 2026
Textron Inc. (NYSE: TXT) strengthens Asia-Pacific support with Essendon Fields expansion
APAC aircraft demand is rising faster than service capacity. Textron Aviation’s Melbourne bet could reshape regional support economics.
May 5, 2026
Pinnacle Investment Management (ASX: PNI) share price jumps 5% after Pacific Asset Management completion
Pinnacle just closed the $419m PAM deal and the stock bounced 5%. Affiliate FUM hits $202.5bn. Performance fees are the next test in July.
May 5, 2026
Persistent Systems (NSE: PERSISTENT) grows at five times Infosys’s guided pace in FY26 as AI deal wins accelerate
Persistent Systems posts $1.65B FY26 revenue with 17.4% growth and 15.6% EBIT margin. Read what the 24th consecutive growth quarter signals for Indian IT. →
April 21, 2026
Atomos (ASX: AMS) bets on new product cycle and NAB Show 2026 to lock in its turnaround
Atomos (ASX: AMS) returned to profit in H1 FY2026 with 28% revenue growth. Here is the retail investor roadmap for the next phase of its turnaround.
April 7, 2026
Algorae Pharmaceuticals (ASX: 1AI) raises A$4m to fund dual commercial and AI drug discovery growth strategy
Algorae Pharmaceuticals (ASX: 1AI) raises A$3.99m to scale AlgoraeRx commercial portfolio and advance AlgoraeOS AI drug pipeline. Read the full strategic analysis.
April 5, 2026
Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Catapult Sports (ASX: CAT) records 27-28% ACV growth and 50% EBITDA jump in FY26. Read what the dual acquisitions mean for the sports analytics race. Read more.
March 27, 2026
Careteq (ASX: CTQ) raises A$2.2m at steep discount to fund acquisitions and clear debt as stock trades near 52-week low
Careteq (ASX: CTQ) raises A$2.2M via a two-tranche placement at A$0.005 per share to fund acquisitions, repay debt, and support working capital. Read the full analysis.
March 11, 2026